<p>In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021. </p>

In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021.

<p>In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021.&nbsp;</p>

CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans

Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science.

Share CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans

Sign up to save your podcasts

CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans

CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans